Skip to main content Skip to section navigation Skip to footer
Back to checkpointtx.com

Checkpoint Therapeutics, Inc.

Investor Relations
  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
May 22, 2020

Checkpoint Therapeutics to Host Virtual Annual Meeting of Stockholders

May 06, 2020

Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights

Apr 21, 2020

Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody Cosibelimab

Mar 11, 2020

Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights

Jan 13, 2020

Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

Nov 20, 2019

Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock

Nov 19, 2019

Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

Nov 08, 2019

Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 07, 2019

Checkpoint Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Sep 30, 2019

Checkpoint Therapeutics Announces Presentation of Positive Interim Clinical Results for Anti-PD-L1 Cosibelimab at the European Society for Medical Oncology (ESMO) Congress 2019

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Checkpoint Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.